King Pharmaceuticals KG International — Year 4
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's international — year 4.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's international — year 4?
- King Pharmaceuticals (KG) reported international — year 4 of -0.3% in Q4 2025.
- What does international — year 4 mean?
- Represents the financial performance and operational results of the International insurance product line during the fourth year of the reporting cycle. This metric captures revenue, underwriting outcomes, and risk exposure specific to international markets. It serves as a baseline for evaluating long-term growth trends within the global segment.